Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Lechmann

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
International Archives of Allergy and Immunology|October 31, 2002
Role of CD83 in the immunomodulation of dendritic cellsMatthias Lechmann, Elisabeth Zinser, Antje Golka, et al.
Immunobiology|October 16, 2004
The soluble form of CD83 dramatically changes the cytoskeleton of dendritic cellsNicole Kotzor, Matthias Lechmann, Elisabeth Zinser, et al.
Protein Expression and Purification|April 2, 2002
Overexpression, purification, and biochemical characterization of the extracellular human CD83 domain and generation of monoclonal antibodiesMatthias Lechmann, Elisabeth Kremmer, Heinrich Sticht, et al.
Trends in Immunology|June 20, 2002
CD83 on dendritic cells: more than just a marker for maturationMatthias Lechmann, Susanne Berchtold, Joachim Hauber, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2008
The CD83 reporter mouse elucidates the activity of the CD83 promoter in B, T, and dendritic cell populations in vivoMatthias Lechmann, Naomi Shuman, Andrew Wakeham, et al.
Immunobiology|August 22, 2006
Determination of the inhibitory activity and biological half-live of soluble CD83: comparison of wild type and mutant isoformsElisabeth Zinser, Matthias Lechmann, Antje Golka, et al.
The Journal of Experimental Medicine|August 4, 2004
Prevention and treatment of experimental autoimmune encephalomyelitis by soluble CD83Elisabeth Zinser, Matthias Lechmann, Antje Golka, et al.
Biochemical and Biophysical Research Communications|February 22, 2005
CD83 is a dimer: Comparative analysis of monomeric and dimeric isoformsMatthias Lechmann, Nicole Kotzor, Elisabeth Zinser, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|November 20, 2012
Murine whole-organ immune cell populations revealed by multi-epitope-ligand cartographyJenny Eckhardt, Christian Ostalecki, Katarzyna Kuczera, et al.
Journal of the American Chemical Society|June 19, 2008
Aptamer-facilitated biomarker discovery (AptaBiD)Maxim V Berezovski, Matthias Lechmann, Michael U Musheev, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
International Archives of Allergy and Immunology|October 31, 2002
Role of CD83 in the immunomodulation of dendritic cellsMatthias Lechmann, Elisabeth Zinser, Antje Golka, et al.
Immunobiology|October 16, 2004
The soluble form of CD83 dramatically changes the cytoskeleton of dendritic cellsNicole Kotzor, Matthias Lechmann, Elisabeth Zinser, et al.
Protein Expression and Purification|April 2, 2002
Overexpression, purification, and biochemical characterization of the extracellular human CD83 domain and generation of monoclonal antibodiesMatthias Lechmann, Elisabeth Kremmer, Heinrich Sticht, et al.
Trends in Immunology|June 20, 2002
CD83 on dendritic cells: more than just a marker for maturationMatthias Lechmann, Susanne Berchtold, Joachim Hauber, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2008
The CD83 reporter mouse elucidates the activity of the CD83 promoter in B, T, and dendritic cell populations in vivoMatthias Lechmann, Naomi Shuman, Andrew Wakeham, et al.
Immunobiology|August 22, 2006
Determination of the inhibitory activity and biological half-live of soluble CD83: comparison of wild type and mutant isoformsElisabeth Zinser, Matthias Lechmann, Antje Golka, et al.
The Journal of Experimental Medicine|August 4, 2004
Prevention and treatment of experimental autoimmune encephalomyelitis by soluble CD83Elisabeth Zinser, Matthias Lechmann, Antje Golka, et al.
Biochemical and Biophysical Research Communications|February 22, 2005
CD83 is a dimer: Comparative analysis of monomeric and dimeric isoformsMatthias Lechmann, Nicole Kotzor, Elisabeth Zinser, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|November 20, 2012
Murine whole-organ immune cell populations revealed by multi-epitope-ligand cartographyJenny Eckhardt, Christian Ostalecki, Katarzyna Kuczera, et al.
Journal of the American Chemical Society|June 19, 2008
Aptamer-facilitated biomarker discovery (AptaBiD)Maxim V Berezovski, Matthias Lechmann, Michael U Musheev, et al.
Pageof 2